← Pharmacy curriculum
Module 15810 lessonsRxPrep 2023 Chapter 23, reconciled with current CDC pediatric outpatient guidance, the AAP acute otitis media guideline and decision tools, the 2024 to 2027 AAP Red Book, the 2022 AAO-HNS tympanostomy tube guideline, and current amoxicillin-clavulanate labeling

Acute Otitis Media

Diagnose true middle-ear infection, control pain, select observation or antibiotics through age and severity, calculate pediatric regimens precisely, and protect hearing and development through closed-loop follow-up.

01

Explain how eustachian-tube dysfunction produces middle-ear pressure, effusion, and infection.

02

Distinguish acute otitis media from otitis media with effusion and acute otitis externa.

03

Apply tympanic-membrane bulging, otorrhea, otalgia, erythema, and effusion criteria accurately.

04

Treat pain independently from the antibiotic decision.

05

Choose immediate antibiotics or 48 to 72 hour observation through age, laterality, otorrhea, severity, and follow-up reliability.

06

Select amoxicillin or amoxicillin-clavulanate through recent exposure, conjunctivitis, recurrence, and beta-lactamase risk.

07

Translate an allergy label into a reaction phenotype and evidence-based alternative pathway.

08

Calculate weight-based dose, concentration, volume, clavulanate exposure, duration, and caregiver schedule.

09

Reassess failure and complications rather than extending or broadening treatment reflexively.

10

Manage residual effusion, recurrent infection, tympanostomy questions, prevention, hearing, and developmental follow-up.

158.01

Connect the Nasopharynx to the Middle Ear

The eustachian tube ventilates and clears the middle ear. Viral inflammation, immature anatomy, adenoid tissue, pressure change, and mucus can impair that function, creating negative pressure and effusion that supports bacterial growth.

What to learn
  • Eustachian tube
  • Middle-ear pressure
  • Effusion
  • Viral trigger
  • Bacterial superinfection
Middle-ear pathwayFollow pressure, fluid, and organisms from the nasopharynx
01InflameViral mucosa

Upper respiratory inflammation narrows the eustachian tube.

02ObstructVentilation

Negative pressure and impaired clearance retain middle-ear fluid.

03AscendBacteria

Nasopharyngeal organisms enter the fluid-filled space.

04ResolveClearance

Inflammation improves before every trace of fluid disappears.

Start with ventilation and clearance

The eustachian tube balances pressure and moves secretions toward the nasopharynx. In young children it is shorter, more horizontal, and less efficient, which helps explain their higher disease burden.

Place the viral trigger first

A viral upper respiratory infection can cause mucosal edema and obstruction. Middle-ear fluid can then become infected by organisms ascending from the nasopharynx.

Name the common bacteria

Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella catarrhalis are central bacterial pathogens. Their resistance mechanisms shape amoxicillin and clavulanate selection.

Separate anatomy from diagnosis

Effusion can persist after infection resolves and can occur without acute bacterial disease. Fluid is required for the AOM diagnosis, but fluid alone is not sufficient.

0 of 1 answered
01Why does a viral upper respiratory infection increase AOM risk?
Answer every question to submit.
158.02

Require Bulging or New Otorrhea, Not Redness Alone

Definitive pediatric diagnosis requires moderate or severe tympanic-membrane bulging or new otorrhea not caused by otitis externa, or mild bulging plus recent otalgia or intense erythema. Middle-ear effusion must be present.

What to learn
  • Bulging membrane
  • New otorrhea
  • Recent otalgia
  • Intense erythema
  • Middle-ear effusion
Diagnostic lensRequire acute inflammation and middle-ear effusion
01SeeBulging

Moderate or severe bulging is highly specific.

02TraceOtorrhea

Exclude external-canal disease before calling perforation.

03PairMild findings

Add recent otalgia or intense erythema.

04ProveEffusion

Use mobility or tympanometry to confirm fluid.

Use the highest-certainty signs

Moderate or severe bulging strongly supports AOM. New otorrhea can indicate tympanic-membrane rupture when external-canal infection is excluded.

Use mild bulging with context

Mild bulging requires recent ear pain within 48 hours or intense membrane erythema. Crying, fever, and instrumentation can redden a membrane without proving AOM.

Prove middle-ear fluid

Pneumatic otoscopy assesses membrane mobility, while tympanometry can support effusion detection. A normal freely mobile membrane argues against middle-ear effusion.

Improve the view

Cerumen, a narrow canal, poor positioning, or an uncooperative child can limit accuracy. Safe cerumen removal, appropriate speculum, stabilization, and skilled reassessment are better than treating an unseen membrane.

0 of 1 answered
01Which finding most strongly supports a definite AOM diagnosis?
Answer every question to submit.
158.03

Separate Infection From Fluid, Canal Disease, and Referred Pain

AOM is one cause of ear pain. Otitis media with effusion lacks acute infection, otitis externa localizes to the canal, and dental, throat, jaw, trauma, foreign body, sudden hearing loss, or mastoid disease can require a different pathway.

What to learn
  • Otitis media with effusion
  • Otitis externa
  • Referred pain
  • Mastoiditis
  • Sudden hearing loss
Ear localizationMove from symptom to the responsible structure
01CanalExternal

Tragal pain and edema support otitis externa.

02MiddleAOM or OME

Bulging defines infection while isolated fluid defines effusion.

03MastoidUrgent

Swelling or auricular displacement can signal extension.

04NeuralProtect

Sudden hearing or neurologic change needs another pathway.

Distinguish residual fluid

Otitis media with effusion can reduce hearing or create fullness without acute bulging, marked pain, or systemic illness. Antibiotics, antihistamines, and decongestants do not routinely clear uncomplicated effusion.

Localize canal disease

Tragal or pinna tenderness, canal edema, and canal debris support acute otitis externa. New middle-ear otorrhea can coexist with a perforation, so inspect the canal and membrane when possible.

Recognize mastoid danger

Postauricular swelling, mastoid tenderness, auricular displacement, severe persistent pain, systemic toxicity, cranial findings, or poor response raises concern for mastoiditis or another complication and needs urgent evaluation.

Protect hearing and neurology

Sudden unilateral hearing loss, severe vertigo, facial weakness, severe headache, meningismus, or other neurologic findings should not be managed as routine AOM.

0 of 1 answered
01Which finding most strongly suggests acute otitis externa rather than AOM?
Answer every question to submit.
158.04

Treat Pain Whether or Not an Antibiotic Is Used

Antibiotics do not provide immediate analgesia. Every child needs a pain plan matched to age, weight, severity, hydration, organ function, caregiver capability, and the expected first 24 to 48 hours.

What to learn
  • Acetaminophen
  • Ibuprofen
  • Weight-based dosing
  • Hydration
  • Return precautions
Comfort planTreat pain while the disease strategy takes effect
01MeasureSeverity

Use sleep, feeding, play, and function.

02DoseBy weight

Calculate acetaminophen or ibuprofen safely.

03DeliverPrecisely

Match concentration, volume, interval, and device.

04RecheckTrajectory

Define worsening and the expected response window.

Assess pain directly

Ask about sleep, feeding, play, crying, school, and function in addition to a numeric score. Otalgia can remain substantial while the infection begins to improve.

Choose a safe systemic analgesic

Acetaminophen and ibuprofen can be effective when age and patient factors permit. Verify current weight, duplicate ingredients, kidney or liver disease, dehydration, bleeding risk, allergy, and exact product concentration.

Avoid unreliable topical shortcuts

A perforation, tube, unknown membrane status, and product-specific labeling change topical exposure. Do not place unverified oil, anesthetic, or home remedies into an ear without a safe membrane and product plan.

Explain the response window

Pain should begin improving as inflammation resolves. Worsening pain, dehydration, new swelling, persistent fever, lethargy, mastoid change, neurologic findings, or failure to improve requires reassessment.

0 of 1 answered
01Why is an antibiotic prescription not a complete AOM treatment plan?
Answer every question to submit.
158.05

Use Observation Only When the Safety System Is Complete

Selected nonsevere cases can be observed for 48 to 72 hours with analgesia and shared decision-making. Observation is an active plan with reliable follow-up and rescue treatment, not delayed responsibility.

What to learn
  • Age
  • Laterality
  • Otorrhea
  • Severity
  • Follow-up reliability
Treatment matrixCombine age, ears, otorrhea, severity, and access
01TreatSevere or draining

Immediate antibiotics fit severe disease or otorrhea.

02ObserveSelected

Nonsevere disease can use 48 to 72 hours.

03SupportAnalgesia

Observation never means withholding pain care.

04RescueReliable

Create a prescription or reassessment mechanism.

Treat severe disease promptly

Otorrhea, toxic appearance, severe or persistent otalgia, or temperature at least 39 degrees Celsius favors immediate antibiotics. Children younger than 6 months fall outside the standard observation population.

Use the age and laterality matrix

For children 6 through 23 months, nonsevere unilateral AOM without otorrhea can be observed, while bilateral disease is treated. For children at least 24 months, nonsevere unilateral or bilateral disease can be observed when follow-up is reliable.

Build a rescue mechanism

A delayed prescription, scheduled recheck, or dependable same-day access must allow antibiotics to begin if symptoms worsen or fail to improve within 48 to 72 hours.

Share the tradeoff honestly

Immediate antibiotics produce a modest average symptom benefit while adding diarrhea, rash, allergy, and selection pressure. Observation reduces unnecessary exposure but requires monitoring and access.

0 of 1 answered
01Which child is an appropriate observation candidate when follow-up is reliable?
Answer every question to submit.
158.06

Preserve High-Dose Amoxicillin as the Focused First Choice

High-dose amoxicillin remains first-line for many children because it targets susceptible and intermediate pneumococcus with a focused spectrum, established middle-ear exposure, familiar formulation, and favorable tolerability.

What to learn
  • Amoxicillin
  • Eighty to ninety mg per kg per day
  • Pneumococcus
  • Focused spectrum
  • Recent exposure
Focused first lineUse enough amoxicillin without unnecessary breadth
01ConfirmAOM

Apply strict diagnostic criteria before prescribing.

02ScreenExceptions

Review recent exposure, conjunctivitis, failure, and allergy.

03CalculateHigh dose

Use 80 to 90 mg per kg per day under protocol.

04LimitDuration

Match the course to age and severity.

Use the conventional high-dose regimen

AAP decision tools use 80 to 90 mg per kg per day divided twice daily, up to the protocol maximum. Calculate from current weight and the amoxicillin component.

Know when amoxicillin fits

It is preferred when the child has not received amoxicillin within 30 days, has no concurrent purulent conjunctivitis, and has no history of recurrent AOM unresponsive to amoxicillin.

Connect dose to pharmacology

Amoxicillin is a beta-lactam that binds penicillin-binding proteins. Its efficacy tracks the time free drug remains above the organism's minimum inhibitory concentration, so dose, interval, absorption, and adherence shape exposure.

Keep duration age-specific

Current AAP Red Book guidance uses 10 days for children younger than 2 years or with severe symptoms, 7 days for ages 2 through 5 with nonsevere disease, and 5 days for children older than 6 with nonsevere disease.

0 of 1 answered
01Which child most clearly fits high-dose amoxicillin first-line therapy?
Answer every question to submit.
158.07

Add Clavulanate for a Defined Beta-Lactamase Problem

Amoxicillin-clavulanate is selected when recent amoxicillin, purulent conjunctivitis, or recurrent AOM unresponsive to amoxicillin raises beta-lactamase risk. Allergy alternatives depend on the reaction phenotype, not the word penicillin alone.

What to learn
  • Beta-lactamase
  • Purulent conjunctivitis
  • Recent amoxicillin
  • Fourteen to one ratio
  • Allergy phenotype
Selection forkAdd spectrum or change class only for a defined reason
01DetectBeta-lactamase risk

Recent amoxicillin and conjunctivitis change the likely organism.

02ProtectAmoxicillin

Clavulanate blocks selected beta-lactamases.

03ChooseRatio

ES-600 supports high amoxicillin with lower clavulanate burden.

04PhenotypeAllergy

Separate intolerance, immediate allergy, and severe delayed disease.

Explain clavulanate's role

Clavulanate inhibits selected beta-lactamases, protecting amoxicillin against beta-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis. It adds gastrointestinal burden and does not solve every resistance mechanism.

Use the high-dose pediatric ratio

The ES-600 suspension supplies 600 mg amoxicillin and 42.9 mg clavulanate per 5 mL, supporting about a 14 to 1 ratio and 90 mg per kg per day of amoxicillin with 6.4 mg per kg per day of clavulanate divided twice daily.

Phenotype the allergy

Clarify culprit, timing, hives, angioedema, bronchospasm, hypotension, mucosal or blistering disease, organ injury, treatment, and later tolerated beta-lactams. Mild delayed rash and severe immediate or delayed reactions do not share one pathway.

Avoid reflexive macrolides

Azithromycin and related alternatives can have limited activity against common AOM pathogens because of resistance. Use AAP-supported cephalosporins when the evaluated phenotype permits and seek specialist guidance for severe reactions or repeated failure.

0 of 1 answered
01Why is the ES-600 formulation useful for high-dose AOM therapy?
Answer every question to submit.
158.08

Turn Milligrams per Kilogram Into a Schedule a Family Can Deliver

Pediatric safety depends on moving correctly from weight to daily milligrams, divided dose, product concentration, measurable volume, bottle quantity, storage, shaking, device selection, and missed-dose counseling.

What to learn
  • Kilograms
  • Daily milligrams
  • Divided dose
  • Milligrams per milliliter
  • Dispense quantity
Dose translationCarry units from the scale to the oral syringe
01Convertkg

Verify weight and convert units safely.

02Multiplymg per day

Apply the indication-specific weight-based regimen.

03Dividemg per dose

Use the prescribed frequency.

04DelivermL

Use concentration, measurable volume, quantity, and device.

Calculate in the right order

Multiply kilograms by the prescribed mg per kg per day, divide by doses per day, then divide milligrams per dose by milligrams per mL. Round only at the final measurable volume unless the protocol directs otherwise.

Read combination labels carefully

Amoxicillin-clavulanate regimens are usually stated by the amoxicillin component. The bottle lists both components, and formulations are not freely interchangeable because clavulanate exposure changes.

Build the complete administration plan

Use an oral syringe for small volumes, shake suspension well, follow current storage and beyond-use instructions, administer at the start of a meal for clavulanate tolerability and absorption, and avoid household spoons.

Dispense enough but not vaguely

Multiply mL per dose by doses per day and duration, then account for practical measuring and product packaging under pharmacy policy. Reconstituted concentration and total volume must match the prescribed course.

0 of 1 answered
01A 20 kg child receives amoxicillin 90 mg/kg/day divided twice daily. How many milligrams are in each dose?
Answer every question to submit.
158.09

Reassess the Diagnosis and Delivery at 48 to 72 Hours

Persistent or worsening symptoms can reflect an incorrect diagnosis, poor delivery, resistant organism, new viral illness, complication, or host factor. Failure is a reason to re-examine the child, not merely to extend the calendar.

What to learn
  • Forty-eight to seventy-two hours
  • Adherence
  • Resistant pathogen
  • Ceftriaxone
  • Mastoid complication
Nonresponse auditRe-examine before escalating
01ConfirmDiagnosis

Repeat otoscopy and localize the source.

02VerifyDelivery

Check concentration, mL, shaking, vomiting, and missed doses.

03EscalateCoverage

Change therapy only after a defined failure.

04ProtectComplications

Mastoid or neurologic signs require urgent care.

Confirm true failure

Symptoms should begin improving within 48 to 72 hours. Middle-ear effusion can persist after pain and fever resolve, so fluid alone is not proof that the antibiotic failed.

Find the correctable cause

Wrong concentration, household-spoon dosing, incomplete shaking, poor taste, vomiting, missed doses, inadequate analgesia, or an incorrect initial diagnosis can mimic resistance.

Escalate with purpose

If amoxicillin fails and the diagnosis remains secure, high-dose amoxicillin-clavulanate is a standard next step. Ceftriaxone for three days and tympanocentesis or specialist pathways can fit repeated failure under current guidance.

Recognize complications

Mastoiditis, facial weakness, labyrinthine symptoms, severe headache, meningismus, systemic toxicity, dehydration, or persistent severe pain needs urgent evaluation rather than routine outpatient cycling.

0 of 1 answered
01A child's pain and fever resolve, but middle-ear effusion remains one week later. What is the best interpretation?
Answer every question to submit.
158.10

Protect Hearing and Development Beyond the Acute Episode

Recurrent AOM, chronic effusion, speech or language concern, hearing difficulty, and structural change require longitudinal care. Prevention reduces respiratory triggers and exposure without using chronic prophylactic antibiotics.

What to learn
  • Recurrent AOM
  • Tympanostomy tubes
  • Hearing test
  • Vaccination
  • Smoke exposure
Longitudinal loopCount episodes while protecting hearing and development
01CountDistinct episodes

Use three in 6 months or four in 12 months.

02ExamineEffusion

Tube candidacy depends on current middle-ear fluid.

03HearDevelopment

Persistent fluid requires hearing and learning surveillance.

04PreventDurably

Use vaccines, smoke avoidance, and family support.

Define recurrence accurately

Recurrent AOM means at least three well-documented episodes in 6 months or four in 12 months with one in the preceding 6 months. Long-term prophylactic antibiotics are not recommended.

Use effusion to guide tube decisions

The 2022 AAO-HNS guideline advises against tympanostomy tubes for recurrent AOM when no middle-ear effusion is present at candidacy assessment. Tubes may be offered when recurrence and effusion coexist after shared decision-making.

Follow persistent effusion and hearing

Obtain age-appropriate hearing evaluation when effusion persists at least 3 months or at any duration in a child at developmental risk. Counsel about speech, language, learning, and balance when bilateral effusion affects hearing.

Prevent with durable measures

Maintain current pneumococcal and annual influenza vaccination, support breastfeeding, avoid tobacco smoke exposure, and reduce avoidable respiratory exposure when feasible. These measures have broader health value and do not replace accurate diagnosis.

0 of 1 answered
01Which child with recurrent AOM most clearly fits tympanostomy-tube consideration?
Answer every question to submit.

Check the connections.

Each attempt draws 10 questions from the complete 168 question bank.

168 questions in this module bank10 questions per attempt

Each attempt draws a fresh set and rearranges the answer choices.

Current clinical foundation.

Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.

  1. CDC outpatient clinical care for pediatric populations
  2. AAP diagnosis and management of acute otitis media
  3. AAP Red Book 2024 to 2027 systems-based treatment table
  4. AAO-HNS tympanostomy tubes in children update
  5. DailyMed Augmentin ES-600 labeling
PharmacyOpen tools